Our data shows that PBT stimulates an anti-tumor immune effect that is T-cell dependent since the anti-tumor effect of PBT was lost in mice where CD4+ and CD8+ T cells were antibody-depleted. The gene discussed is CD8A; the disease is neoplasm.